145.42 USD
↘ 2.74 (1.85%)AT CLOSE (11:59 AM EDT)
Insulet Corporation
PODDNASDAQ • USD
145.88
↗ 0.46 (0.32%)
POST MARKET (AS OF 08:00 PM EDT)
Post Market
AS OF 08:00 PM EDT
145.88
↗ 0.46 (0.32%)
Market: CLOSED
PODD is currently priced at $145.46. PODD shows a split signal: underlying fundamentals suggest "Buy" while technical indicators indicate "Sell". This is driven by a robust Altman Z-Score, exceptional Return on Equity (26.4%), a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On valuation, PODD trades roughly in line with sector averages — neither particularly cheap nor expensive.
Technical & fundamental data as of Aug 24, 2026.
Open?$151.17
High?$151.75
Low?$145.15
Prev. Close?$148.16
Volume?1.6M
Avg. Volume?1.6M
VWAP?$146.79
Rel. Volume?0.96x
Bid / Ask
Bid?$142.03 × 100
Ask?$148.55 × 100
Spread?$6.52
Midpoint?$145.29
Valuation & Ratios
Market Cap?10.3B
Shares Out?69.4M
Float?69.0M
Float %?99.6%
P/E Ratio?27.38
P/B Ratio?7.23
EPS?$5.41
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, more than 600,000 insulin-dependent diabetic patients are using it worldwide.
Themes
Employees
5.4K
Market Cap
10.3B
Industry
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Website
Listed
2007-05-15
Address
100 NAGOG PARK
ACTON, MA 01720
Phone: 978-600-7000
ACTON, MA 01720
Phone: 978-600-7000
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookBuy
Strong SellNeutralStrong Buy
F-Score?77
Z-Score?99
Momentum?80
Short Sent.?59
Piotroski F-Score?6/9Mixed
Altman Z-Score?5.67Safe
Confidence?73%Moderate
Short InterestElevated
Short % of Float?5.56%Elevated
Short Interest?3.8M
Days to Cover?3.0
Free Float69.0M
Avg Daily Volume1.3M
Settlement Date2026-07-31
Financial Health
Current Ratio?2.48Strong
Quick Ratio?1.83Adequate
Cash Ratio?0.72Adequate
Debt/Equity?0.67Moderate
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score61/100
P/E?27.4FAIR▾
Peers100
S&P41
P/B?7.23FAIR▾
Peers100
S&P26
P/S?3.37FAIR▾
Peers100
S&P46
P/FCF?36.4PRICEY▾
Peers100
S&P20
EV/EBITDA?17.4FAIR▾
Peers100
S&P36
EV/Sales?3.50FAIR▾
Peers100
S&P54
Returns & Efficiency
ROE?26.4%STRONG▾
Peers50
S&P76
ROA?11.9%STRONG▾
Peers50
S&P80
Cash Flow & Enterprise
FCF?$282.5M
Enterprise Value?$10.7B
Fundamentals ratios updated end of day